Filed Pursuant to Rule 424(b)(3) Registration No. 333-110719 PROSPECTUS SUPPLEMENT (TO PROSPECTUS DATED DECEMBER 2, 2003) $175,000,000 TRIARC COMPANIES, INC. 5% CONVERTIBLE NOTES DUE 2023 AND SHARES OF CLASS A COMMON STOCK AND CLASS B COMMON STOCK, SERIES 1, ISSUABLE UPON CONVERSION OF THE NOTES __________________ This prospectus supplement supplements our prospectus dated December 2, 2003, relating to the offer and resale by various selling securityholders of up to $175,000,000 aggregate principal amount of our 5% Convertible Notes due 2023 and shares of our Class A common stock and Class B common stock, Series 1, into which the notes are convertible. This prospectus supplement should be read in conjunction with, and may not be delivered or utilized without, the prospectus and the previous prospectus supplements. This prospectus supplement is qualified by reference to the prospectus, as supplemented, except to the extent that the information in this prospectus supplement supersedes the information contained therein. The information in the table contained under the heading "Selling Securityholders" beginning on page 62 of the prospectus is hereby amended by superseding the information with respect to the person previously listed in a supplement to the prospectus that is listed below: ------------------------------------------------------------------------------------------------------------------------ NUMBER OF SHARES OF CLASS PERCENTAGE OF PERCENTAGE OF PRINCIPAL NUMBER OF SHARES B COMMON STOCK, CLASS A COMMON CLASS B COMMON AMOUNT OF NOTES OF CLASS A SERIES 1, STOCK STOCK, SERIES 1, BENEFICIALLY COMMON STOCK BENEFICIALLY BENEFICIALLY BENEFICIALLY OWNED AND BENEFICIALLY OWNED AND OWNED AFTER OWNED AFTER OFFERED OWNED AND OFFERED COMPLETION OF COMPLETION OF SELLING SECURITYHOLDER HEREBY($) OFFERED HEREBY(1) HEREBY(2) THE OFFERING(%) THE OFFERING(%) ------------------------------------------------------------------------------------------------------------------------ Morgan Stanley & Co. Incorporated (3)..... 128,000 3,200 6,400 * * ------------------------------------------------------------------------------------------------------------------------ * Less than one percent ---------------------------------------- (1) Includes shares of Class A common stock issuable upon conversion of the notes, and assumes a conversion rate of 25 shares per $1,000 principal amount of the notes, which conversion rate is subject to adjustment as described under "Description of the Notes--Conversion of Notes" in the prospectus. Accordingly, the number of shares of Class A common stock issuable upon conversion of the notes may increase or decrease from time to time. Under the terms of the indenture, we will not issue fractional shares of Class A common stock upon conversion of the notes and, in lieu thereof, will pay cash. (2) Includes shares of Class B common stock, Series 1, issuable upon conversion of the notes, and assumes a conversion rate of 50 shares per $1,000 principal amount of the notes, which conversion rate is subject to adjustment as described under "Description of the Notes--Conversion of Notes" in the prospectus. Accordingly, the number of shares of Class B common stock, Series 1, issuable upon conversion of the notes may increase or decrease from time to time. Under the terms of the indenture, we will not issue fractional shares of Class B common stock, Series 1, upon conversion of the notes and, in lieu thereof, will pay cash. (3) Morgan Stanley & Co. Incorporated beneficially owns an additional 38,400 shares of Class A common stock and an additional 75,798 shares of Class B common stock, Series 1, that are not offered. _______________ INVESTING IN THE SECURITIES OFFERED BY THE PROSPECTUS AND THIS PROSPECTUS SUPPLEMENT INVOLVES RISKS. SEE "RISK FACTORS" BEGINNING ON PAGE 12 OF THE PROSPECTUS. _______________ Neither the Securities and Exchange Commission, nor any state securities commission, has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the prospectus. Any representation to the contrary is a criminal offense. THIS PROSPECTUS SUPPLEMENT IS DATED DECEMBER 7, 2004